Endocrine Therapy Alone Is Sufficient in HR+/HER2- Breast Cancer With Intermediate Recurrence Score

Press/Media

Period	9 Jun 2019

Media coverage

Title	Endocrine Therapy Alone Is Sufficient in HR+/HER2- Breast Cancer With Intermediate Recurrence Score
Media name/outlet	OncLive
Country/Territory	United States
Date	9/06/19
URL	https://www.onclive.com/conference-coverage/asco-2018/endocrine-therapy-alone-is-sufficient-in-hrher2-breast-cancer-with-intermediate-recurrence-score
Persons	Joseph Sparano